BAL PHARMA Q3 FY25 Results
BAL PHARMA has released its financial results for the Q3 quarter of Financial Year 24-2025. Here's a comprehensive breakdown of the company's performance:
Revenue Analysis
- Current Quarter Revenue: Rs. 73.15 Cr
- Quarter-on-Quarter (QoQ) Change: -0.73% (Previous Quarter: Rs. 73.69 Cr )
- Year-on-Year (YoY) Change: -10.42% (Same Quarter Last Year: Rs. 81.66 Cr )
Profitability Metrics
- Net Profit: Rs. 0.52 Cr
- QoQ Profit Change: -50.26% (Previous Quarter: Rs. 1.04 Cr )
- YoY Profit Change: -39.01% (Same Quarter Last Year: Rs. 0.85 Cr )
Shareholder Returns
- Earnings Per Share (EPS): Rs. 0.33
- QoQ EPS Change: -49.23% (Previous Quarter: Rs. 0.65)
- YoY EPS Change: -38.89% (Same Quarter Last Year: Rs. 0.54)
Performance Summary
Challenging
BAL PHARMA experienced notable declines in both sales and profits. The company might be going through a transition period.
This analysis provides a snapshot of BAL PHARMA's financial performance. Investors and analysts should consider these results in the context of broader market trends and the company's long-term strategy.
Disclaimer:
This information is for informational purposes only. Please reverify all details from official sources before making any financial decisions. The accuracy and completeness of this data cannot be guaranteed.